Literature DB >> 7477008

Species-specific 18S rRNA gene amplification for the detection of P. falciparum and P. vivax malaria parasites.

A Das1, B Holloway, W E Collins, V P Shama, S K Ghosh, S Sinha, S E Hasnain, G P Talwar, A A Lal.   

Abstract

Based on the sequence diversity of the Plasmodium 18S ribosomal RNA (rRNA), we designed oligonucleotide primers for polymerase chain reaction (PCR) to yield different size fragments for P. falciparum and P. vivax. The primers for the PCR procedure were chosen such that the 5' primer was Plasmodium-conserved while the 3' primers were species-specific. Using primer cocktails and cloned plasmid DNAs containing the 18S rRNA genes or parasite genomic DNA as targets, we show that the PCR procedure yields 1.4-kb and 0.5-kb DNA fragments for P. falciparum and P. vivax, respectively. Limited field testing of this procedure demonstrated the utility of a ribosomal gene based species-specific malaria diagnosis.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 7477008     DOI: 10.1006/mcpr.1995.0025

Source DB:  PubMed          Journal:  Mol Cell Probes        ISSN: 0890-8508            Impact factor:   2.365


  13 in total

1.  Real-time quantitative reverse transcription PCR for monitoring of blood-stage Plasmodium falciparum infections in malaria human challenge trials.

Authors:  Sean C Murphy; Jennifer L Prentice; Kathryn Williamson; Carolyn K Wallis; Ferric C Fang; Michal Fried; Cris Pinzon; Ruobing Wang; Angela K Talley; Stefan H I Kappe; Patrick E Duffy; Brad T Cookson
Journal:  Am J Trop Med Hyg       Date:  2012-03       Impact factor: 2.345

2.  Standardization of a very specific and sensitive single PCR for detection of Plasmodium vivax in low parasitized individuals and its usefulness for screening blood donors.

Authors:  Kátia Luz Torres; Daniel Vasquez Figueiredo; Mariano Gustavo Zalis; Cláudio Tadeu Daniel-Ribeiro; Wilson Alecrim; Maria de Fátima Ferreira-da-Cruz
Journal:  Parasitol Res       Date:  2006-01-17       Impact factor: 2.289

3.  Real-time fluorescence-based PCR for detection of malaria parasites.

Authors:  May-Ann Lee; Chiew-Hoon Tan; Lay-Tin Aw; Choon-Siang Tang; Mulkit Singh; Sze-Hee Lee; Hwee-Pin Chia; Eric P H Yap
Journal:  J Clin Microbiol       Date:  2002-11       Impact factor: 5.948

4.  Detection of early and single infections of Schistosoma japonicum in the intermediate host snail, Oncomelania hupensis, by PCR and loop-mediated isothermal amplification (LAMP) assay.

Authors:  Takashi Kumagai; Rieko Furushima-Shimogawara; Hiroshi Ohmae; Tian-Ping Wang; Shaohong Lu; Rui Chen; Liyong Wen; Nobuo Ohta
Journal:  Am J Trop Med Hyg       Date:  2010-09       Impact factor: 2.345

5.  Use of molecular beacon probes for real-time PCR detection of Plasmodium falciparum and other plasmodium species in peripheral blood specimens.

Authors:  Sameer Elsayed; Katherine Plewes; Deirdre Church; Barbara Chow; Kunyan Zhang
Journal:  J Clin Microbiol       Date:  2006-02       Impact factor: 5.948

6.  Development and evaluation of a 28S rRNA gene-based nested PCR assay for P. falciparum and P. vivax.

Authors:  Deepak Pakalapati; Shilpi Garg; Sheetal Middha; Jyoti Acharya; Amit K Subudhi; Arunachalam P Boopathi; Vishal Saxena; Sanjay K Kochar; Dhanpat K Kochar; Ashis Das
Journal:  Pathog Glob Health       Date:  2013-06       Impact factor: 2.894

Review 7.  Malaria diagnostics in clinical trials.

Authors:  Sean C Murphy; Joseph P Shott; Sunil Parikh; Paige Etter; William R Prescott; V Ann Stewart
Journal:  Am J Trop Med Hyg       Date:  2013-09-23       Impact factor: 2.345

8.  Plasmodium vivax malaria.

Authors:  Dhanpat K Kochar; Vishal Saxena; Narvachan Singh; Sanjay K Kochar; S Vijay Kumar; Ashis Das
Journal:  Emerg Infect Dis       Date:  2005-01       Impact factor: 6.883

Review 9.  Emerging nucleic acid-based tests for point-of-care detection of malaria.

Authors:  Michael S Cordray; Rebecca R Richards-Kortum
Journal:  Am J Trop Med Hyg       Date:  2012-08       Impact factor: 2.345

10.  External quality assurance of malaria nucleic acid testing for clinical trials and eradication surveillance.

Authors:  Sean C Murphy; Cornelus C Hermsen; Alexander D Douglas; Nick J Edwards; Ines Petersen; Gary A Fahle; Matthew Adams; Andrea A Berry; Zachary P Billman; Sarah C Gilbert; Matthew B Laurens; Odile Leroy; Kristen E Lyke; Christopher V Plowe; Annette M Seilie; Kathleen A Strauss; Karina Teelen; Adrian V S Hill; Robert W Sauerwein
Journal:  PLoS One       Date:  2014-05-16       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.